Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Exogenous Infection
1.2.5 Hematological Diseases
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Treatment Market Perspective (2019-2030)
2.2 Monoclonal Antibody Treatment Growth Trends by Region
2.2.1 Global Monoclonal Antibody Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monoclonal Antibody Treatment Historic Market Size by Region (2019-2024)
2.2.3 Monoclonal Antibody Treatment Forecasted Market Size by Region (2025-2030)
2.3 Monoclonal Antibody Treatment Market Dynamics
2.3.1 Monoclonal Antibody Treatment Industry Trends
2.3.2 Monoclonal Antibody Treatment Market Drivers
2.3.3 Monoclonal Antibody Treatment Market Challenges
2.3.4 Monoclonal Antibody Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Treatment Players by Revenue
3.1.1 Global Top Monoclonal Antibody Treatment Players by Revenue (2019-2024)
3.1.2 Global Monoclonal Antibody Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Treatment Revenue
3.4 Global Monoclonal Antibody Treatment Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Treatment Revenue in 2023
3.5 Monoclonal Antibody Treatment Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Treatment Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Treatment Breakdown Data by Type
4.1 Global Monoclonal Antibody Treatment Historic Market Size by Type (2019-2024)
4.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2025-2030)
5 Monoclonal Antibody Treatment Breakdown Data by Application
5.1 Global Monoclonal Antibody Treatment Historic Market Size by Application (2019-2024)
5.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monoclonal Antibody Treatment Market Size (2019-2030)
6.2 North America Monoclonal Antibody Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monoclonal Antibody Treatment Market Size by Country (2019-2024)
6.4 North America Monoclonal Antibody Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Treatment Market Size (2019-2030)
7.2 Europe Monoclonal Antibody Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monoclonal Antibody Treatment Market Size by Country (2019-2024)
7.4 Europe Monoclonal Antibody Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Treatment Market Size (2019-2030)
8.2 Asia-Pacific Monoclonal Antibody Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Treatment Market Size (2019-2030)
9.2 Latin America Monoclonal Antibody Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monoclonal Antibody Treatment Market Size by Country (2019-2024)
9.4 Latin America Monoclonal Antibody Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Treatment Market Size (2019-2030)
10.2 Middle East & Africa Monoclonal Antibody Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Monoclonal Antibody Treatment Introduction
11.1.4 Pfizer Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Monoclonal Antibody Treatment Introduction
11.2.4 Bayer Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Monoclonal Antibody Treatment Introduction
11.3.4 Sanofi Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Monoclonal Antibody Treatment Introduction
11.4.4 Merck Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Monoclonal Antibody Treatment Introduction
11.6.4 Roche Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Treatment Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Treatment Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Shanghai Junshi Biosciences Co.,Ltd
11.9.1 Shanghai Junshi Biosciences Co.,Ltd Company Detail
11.9.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview
11.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Introduction
11.9.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development
11.10 Innovent Biologics
11.10.1 Innovent Biologics Company Detail
11.10.2 Innovent Biologics Business Overview
11.10.3 Innovent Biologics Monoclonal Antibody Treatment Introduction
11.10.4 Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.10.5 Innovent Biologics Recent Development
11.11 Jiangsu Hengrui Medicine Co.,Ltd.
11.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
11.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Introduction
11.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
11.12 BeiGene, Ltd.
11.12.1 BeiGene, Ltd. Company Detail
11.12.2 BeiGene, Ltd. Business Overview
11.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Introduction
11.12.4 BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.12.5 BeiGene, Ltd. Recent Development
11.13 Grand Pharmaceutical (China) Co., Ltd
11.13.1 Grand Pharmaceutical (China) Co., Ltd Company Detail
11.13.2 Grand Pharmaceutical (China) Co., Ltd Business Overview
11.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Introduction
11.13.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Development
11.14 Henlius
11.14.1 Henlius Company Detail
11.14.2 Henlius Business Overview
11.14.3 Henlius Monoclonal Antibody Treatment Introduction
11.14.4 Henlius Revenue in Monoclonal Antibody Treatment Business (2019-2024)
11.14.5 Henlius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details